| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |